For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients’ ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

In the first few months of 2026, the news about advancements in cancer research including topics about targeted therapies, early detection and drug development. But to get a better idea of the “how,” ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Study finds similar safety regardless of anticoagulant type.In a study of adults with advanced prostate cancer taking androgen-receptor pathway ...